These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22629834)

  • 1. [Hematoprotective effectiveness of dicarbamin in experimental post-radiation bone marrow syndrome].
    Moiseeva IIa; Zinov'ev AI; Nikishin SA; Nebol'sin VE
    Vopr Onkol; 2012; 58(1):81-4. PubMed ID: 22629834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of the myeloprotective effect of dicarbamine and leucostim in experimental post-radiation bone marrow syndrome].
    Moiseeva IIa; Ionicheva LV; Nikishin SA; Rodina OP; Vodop'ianova OA; Nebol'sin VE
    Vopr Onkol; 2013; 59(4):498, 500-4. PubMed ID: 24032227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of dicarbamine on medullary hemopoiesis in experimental post-irradiation bone-marrow syndrome].
    Moiseeva IIa; Zinov'ev AI; Ionicheva LV; Nikishin SA; Nebol'sin VE; Kinzirskaia IuV
    Vopr Onkol; 2012; 58(5):663-6. PubMed ID: 23600285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of dicarbamin on postradiation leukocyte composition dynamics in peripheral blood of mice].
    Moiseeva IIa; Zinov'ev AI; Mozerova IV; Filimonov SA
    Eksp Klin Farmakol; 2010 Jan; 73(1):20-2. PubMed ID: 20184283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dicarbamin--an effective protector of myelodepression in combined treatment for Hodgkin's disease].
    Gershanovich ML; Filatova LV
    Vopr Onkol; 2007; 53(5):589-95. PubMed ID: 18154127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of hematosupressive action of ionizing radiation by dicarbamine].
    Moiseeva IIa; Ionicheva LV; Nikishin SA; Zinov'ev AI; Nebol'sin VE
    Vopr Onkol; 2013; 59(1):99, 101-4. PubMed ID: 23814834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the hemato-protective effect of Dicarbamine and Leykostime in experimental radiation damage to the blood system].
    Moiseeva IIa; Zinov'ev AI; Ionicheva LV; Nikishin SA; Nebol'sin VE
    Vopr Onkol; 2013; 59(2):71-4, 76-7. PubMed ID: 23814853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytogenetic analysis of bone marrow protection with mexamine in different radiation doses].
    Voĭtkevich ND; Palyga GF; Iarmonenko SP
    Med Radiol (Mosk); 1974 Nov; 19(11):12-7. PubMed ID: 4530889
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytostatic-assisted myelosuppression using dicarbamin, an oral hematoprotector (experimental study)].
    Treshchalin ID; Bodiagin DA; Pereverzeva ER; Treshchalin MI; Nebol'sin VE
    Vopr Onkol; 2009; 55(6):769-74. PubMed ID: 20210024
    [No Abstract]   [Full Text] [Related]  

  • 10. [Danpes in the cellular composition of bone marrow subjected to ultra-high-frequency radiation together with imiphos].
    Sevast'ianova LA; Potapov SL; Vasil'eva NN; Krusanova NI; Kubatkina EI
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1976; (7):36-9. PubMed ID: 990356
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of protective effect of Dicarbamin on the blood system in cytostatic treatment.
    Nebolsin VE; Zhdanov VV; Zyuzkov GN; Udut EV; Khrichkova TY; Simanina EV; Stavrova LA; Miroshnichenko LA; Chaikovskiy AV; Dygai AM
    Bull Exp Biol Med; 2011 Jan; 150(3):343-7. PubMed ID: 21240350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of indometofen on the survival and bone marrow hemopoiesis of mice exposed to acute external gamma- or X-ray irradiation].
    Grebeniuk AN; Bykov VN; Miasnikov VA; Zatsepin VV; Aksenova NV; Drachev IS; Suprunova EB
    Radiats Biol Radioecol; 2011; 51(4):464-70. PubMed ID: 21950104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of aminoethylisothiuronium and 2-aminothiazoline on the level of protein thiols in mouse bone marrow cells].
    Dontsova GV; Smirnova IB; Sokolova OM
    Radiobiologiia; 1974; 14(2):285-7. PubMed ID: 4832887
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indication of protector-modified radioresistance. 3. An analysis of the relationship of the hypoxic and radioprotective effects in the bone marrow of rats in hypoxia of varying origin].
    Rozhdestvenskiĭ LM
    Radiobiologiia; 1981; 21(6):847-53. PubMed ID: 7323272
    [No Abstract]   [Full Text] [Related]  

  • 15. [Radio-protective properties of prodigiozan in experiment].
    Chertkov KS; Vaĭsberg GE; Khramchenkova SP; Rogozkin VD; Ermol'eva ZV
    Antibiotiki; 1969 Nov; 14(11):1026-30. PubMed ID: 4907798
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of phytohemagglutinin on bone marrow repopulation in mice.
    Grünwald HW
    J Med; 1971; 2(3):167-81. PubMed ID: 5289640
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Rapid screening of radioprotective drugs in vivo.
    Heddle JA; Harris JW
    Radiat Res; 1975 Feb; 61(2):350-3. PubMed ID: 1167210
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiation damage and the interferon system.
    Lvovsky E; Baze WB; Hilmas DE; Levy HB
    Tex Rep Biol Med; 1977; 35():388-93. PubMed ID: 358463
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioprotective effect of WR-2721 on haematopoiesis in mice. II. Morphological changes of bone marrow and spleen.
    Macková N; Brezáni P
    Radiobiol Radiother (Berl); 1988; 29(5):595-601. PubMed ID: 2852383
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiomodifying effect of camphor as evaluated by micronuclei frequency and sister chromatid exchanges.
    Goel HC
    Indian J Exp Biol; 1993 Jun; 31(6):571-3. PubMed ID: 8406608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.